ABOS
Price
$1.39
Change
+$0.01 (+0.72%)
Updated
Feb 21 closing price
Capitalization
83.51M
36 days until earnings call
CTMX
Price
$0.78
Change
-$0.04 (-4.88%)
Updated
Feb 21 closing price
Capitalization
61.04M
3 days until earnings call
Ad is loading...

ABOS vs CTMX

Header iconABOS vs CTMX Comparison
Open Charts ABOS vs CTMXBanner chart's image
Acumen Pharmaceuticals
Price$1.39
Change+$0.01 (+0.72%)
Volume$402.19K
Capitalization83.51M
CytomX Therapeutics
Price$0.78
Change-$0.04 (-4.88%)
Volume$458.95K
Capitalization61.04M
ABOS vs CTMX Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. CTMX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and CTMX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ABOS: $1.45 vs. CTMX: $0.80)
Brand notoriety: ABOS and CTMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 50% vs. CTMX: 45%
Market capitalization -- ABOS: $83.51M vs. CTMX: $61.04M
ABOS [@Biotechnology] is valued at $83.51M. CTMX’s [@Biotechnology] market capitalization is $61.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileCTMX’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • CTMX’s FA Score: 0 green, 5 red.
According to our system of comparison, CTMX is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 3 TA indicator(s) are bullish while CTMX’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 3 bullish, 3 bearish.
  • CTMX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CTMX is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а +9.02% price change this week, while CTMX (@Biotechnology) price change was +4.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

ABOS is expected to report earnings on May 20, 2025.

CTMX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($83.5M) has a higher market cap than CTMX($61M). ABOS YTD gains are higher at: -15.698 vs. CTMX (-22.796). CTMX has higher annual earnings (EBITDA): 8.55M vs. ABOS (-77.89M). ABOS has more cash in the bank: 200M vs. CTMX (118M). CTMX has less debt than ABOS: CTMX (10.6M) vs ABOS (28.5M). CTMX has higher revenues than ABOS: CTMX (127M) vs ABOS (0).
ABOSCTMXABOS / CTMX
Capitalization83.5M61M137%
EBITDA-77.89M8.55M-911%
Gain YTD-15.698-22.79669%
P/E RatioN/A4.88-
Revenue0127M-
Total Cash200M118M169%
Total Debt28.5M10.6M269%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSCTMX
RSI
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 6 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 6 days ago
75%
Momentum
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
84%
MACD
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 19 days ago
77%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 6 days ago
70%
Aroon
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
86%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with ABCL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
N/A
ABCL - ABOS
48%
Loosely correlated
+4.89%
ALEC - ABOS
48%
Loosely correlated
+3.53%
AURA - ABOS
48%
Loosely correlated
-3.77%
GBIO - ABOS
47%
Loosely correlated
+2.13%
MGTX - ABOS
47%
Loosely correlated
+1.27%
More